Dario Publishes New Research in Peer Reviewed Journal Demonstrating Improved Outcomes by Race and Ethnicity

DarioHealth Corp., a leader in the global digital therapeutics (DTx) market, announced the publication of new research in the peer-reviewed journal Applied Sciences demonstrating improved outcomes for users living with diabetes across different racial and ethnic groups. The research appears in the journal as part of the Special Issue: Digital Therapeutics Applications for Chronic Disease Management.

Dario’s integrated digital therapeutics platform engages users living with the most common chronic conditions using a combination of smart tools and technologies and human support to deliver a highly individualized experience. The Company’s platform is proven to help users improve their health and maintain results over time.

Recommended AI: ITA Group Launches AI-Powered Channel Sales Claims Management Solution

Racial and ethnic disparities are common in many chronic conditions including diabetes.  Digital health has the opportunity to address these disparities and improve outcomes. The new research examined retrospective data from 1,000 users with Type 2 diabetes who engaged with Dario’s platform across a 12-month period. Data from users who identified as White was compared to the data of those who identified as Black, Latino or Asian. The results showed no statistical difference in the levels of engagement across racial and ethnic groups, and significant improvements in average blood glucose between the first and last month with no statistical difference between racial and ethnic groups:

• 14% reduction in White users.
• 15% reduction in Black, Latino and Asian users.

“We are thrilled to expand our research on the important topic of digital health as a means to help address health inequities. We serve a diverse user population and improving outcomes for everyone is always our goal. This new study provides assurance that our solutions have a positive clinical impact regardless of race or ethnicity,” said Yifat Hershcovitz, PhD, Vice President of Clinical and Scientific Affairs at Dario.

Recommended AI: The Transformational Impact of Low-code on the SaaS Industry in 2023

“Digital health solutions can help bridge historical and structural divisions in traditional care, but to be broadly effective, solutions must continually examine bias and design for individual differences. We are excited to lead in this area and to share this new research demonstrating the effectiveness of Dario’s approach and our ability to make better health accessible for everyone,” said Omar Manejwala, MD, Chief Medical Officer at Dario.

The study was conducted in partnership with Marilyn D. Ritholz, PhD, Senior Psychologist, Joslin Center for Diabetes; David L. Horwitz, President, DLH Biomedical Consulting; and Trisha Donaldson-Pitter, Instructional Design Specialist/co-Lead of the Community Engagement, Outreach and Technical Assistance Core, UConn Health Disparities Institute.

Recommended AI: SaaS Maker 3 Paves Way for New Era of Software Innovation

[To share your insights with us, please write to sghosh@martechseries.com]